TP 83 Feasibility of Screening and Follow-up for Sexually Transmitted Infections (STIs) Using Rapid and Standard STI Testing from a Mobile Health Van

Tuesday, June 10, 2014
Exhibit Hall
Sherine Patterson-Rose, MD, MPH1, Elizabeth Hesse, BS1, Laura Dize, BS2, Charlotte Gaydos, MS, MPH, DrPH2 and Lea Widdice, MD1, 1Division of Adolescent Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Department of Medicine, Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD

Background: To determine feasibility of providing STI services from a mobile health van, free screening was provided twice at an annual public event.

Methods: During Year 1, women, ≥ 14 yr. were offered OSOM® Rapid Trichomonas Test (TV) (Sekisui Diagnostics, Lexington, MA); APTIMA Combo2 (Hologic, Bedford, MA) for chlamydia (CT) and gonorrhea (GC) using self-collected vaginal swabs; and syphilis Rapid Plasma Reagin (RPR). During Year 2, services were expanded for women to include Xpert® CT/NG (Cepheid, Sunnyvale, CA), and to include men, ≥ 14 yr. Men were offered Xpert® CT/NG using urine, standard APTIMA CT/GC using self-collected penile swabs, and RPR. OSOM and all Xpert® tests were completed on the van, providing immediate results. Standard tests (APTIMA and RPR) had a two-week turn-around time. Successful follow-up included contacting, educating, and treating participants with positive rapid/standard results. Rapid Xpert® CT/GC results were confirmed with APTIMA.

Results: In Year 1, 17 women chose screening; 16 consented to research. Sixteen chose TV; 1 (6.3%) was positive. Fifteen chose APTIMA CT/GC; 2 (13.3%) were positive for CT; 1 (6.6%) was positive for GC. Fifteen chose RPR; none were positive. Follow-up was successful except for one woman with CT. In Year 2, 17 women (15 consented for research) and 11 men (all consented) chose screening. Fifteen women chose TV; 3 (20%) were positive. Two chose only standard CT/GC; none were positive. Twelve chose Xpert® CT/NG; 2 (16.7%) were positive for CT; 0 GC positive. Twelve chose RPR; no positives. Among men, one chose standard CT/GC, 10 chose Xpert® CT/NG, 9 chose RPR. None were positive. Follow-up was successful for all participants. Confirmatory APTIMA and Xpert® CT/NG results were identical.  

Conclusions: Men and women will seek STI services on mobile health vans at public events. Rapid tests facilitate successful immediate treatment of positive STI results.